Impacto de un medio audiovisual en la percepción del dispositivo intrauterino tipo T de cobre en el puerperio inmediato en mujeres mayores de edad en el Hospital Local del Norte, Colombia

El objetivo principal de este estudio es conocer el impacto del uso de un medio audiovisual en la percepción sobre el uso del dispositivo intrauterino tipo T de cobre (DIU-Cu) en mujeres mayores de 18 años que se encuentren en las primeras 48 horas de parto vaginal en el hospital Local del Norte, se...

Full description

Autores:
Zúniga Sierra, Eduardo Antonio
Tipo de recurso:
Fecha de publicación:
2023
Institución:
Universidad Autónoma de Bucaramanga - UNAB
Repositorio:
Repositorio UNAB
Idioma:
spa
OAI Identifier:
oai:repository.unab.edu.co:20.500.12749/21121
Acceso en línea:
http://hdl.handle.net/20.500.12749/21121
Palabra clave:
Gynecology
Obstetrics
Medical sciences
Health sciences
Colombia
Contraception
Long-acting reversible contraception
Postpartum period
Intrauterine devices
Family development planning
Birth control
Copper intrauterine contraceptives
Postpartum period
Ginecología
Obstetricia
Ciencias médicas
Control natal
Anticonceptivos intrauterinos de cobre
Periodo posparto
Anticoncepción
Periodo posparto
Anticoncepción reversible de larga duración
Dispositivos intrauterinos
Planificación familiar
Colombia
Ciencias de la salud
Rights
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id UNAB2_9b7f3e0406fc63694b78fd1060c1147f
oai_identifier_str oai:repository.unab.edu.co:20.500.12749/21121
network_acronym_str UNAB2
network_name_str Repositorio UNAB
repository_id_str
dc.title.spa.fl_str_mv Impacto de un medio audiovisual en la percepción del dispositivo intrauterino tipo T de cobre en el puerperio inmediato en mujeres mayores de edad en el Hospital Local del Norte, Colombia
dc.title.translated.spa.fl_str_mv Impact of an audiovisual media on the perception of the copper intrauterine device in the immediate puerperium in women of legal age at the Local del Norte hospital, Colombia
title Impacto de un medio audiovisual en la percepción del dispositivo intrauterino tipo T de cobre en el puerperio inmediato en mujeres mayores de edad en el Hospital Local del Norte, Colombia
spellingShingle Impacto de un medio audiovisual en la percepción del dispositivo intrauterino tipo T de cobre en el puerperio inmediato en mujeres mayores de edad en el Hospital Local del Norte, Colombia
Gynecology
Obstetrics
Medical sciences
Health sciences
Colombia
Contraception
Long-acting reversible contraception
Postpartum period
Intrauterine devices
Family development planning
Birth control
Copper intrauterine contraceptives
Postpartum period
Ginecología
Obstetricia
Ciencias médicas
Control natal
Anticonceptivos intrauterinos de cobre
Periodo posparto
Anticoncepción
Periodo posparto
Anticoncepción reversible de larga duración
Dispositivos intrauterinos
Planificación familiar
Colombia
Ciencias de la salud
title_short Impacto de un medio audiovisual en la percepción del dispositivo intrauterino tipo T de cobre en el puerperio inmediato en mujeres mayores de edad en el Hospital Local del Norte, Colombia
title_full Impacto de un medio audiovisual en la percepción del dispositivo intrauterino tipo T de cobre en el puerperio inmediato en mujeres mayores de edad en el Hospital Local del Norte, Colombia
title_fullStr Impacto de un medio audiovisual en la percepción del dispositivo intrauterino tipo T de cobre en el puerperio inmediato en mujeres mayores de edad en el Hospital Local del Norte, Colombia
title_full_unstemmed Impacto de un medio audiovisual en la percepción del dispositivo intrauterino tipo T de cobre en el puerperio inmediato en mujeres mayores de edad en el Hospital Local del Norte, Colombia
title_sort Impacto de un medio audiovisual en la percepción del dispositivo intrauterino tipo T de cobre en el puerperio inmediato en mujeres mayores de edad en el Hospital Local del Norte, Colombia
dc.creator.fl_str_mv Zúniga Sierra, Eduardo Antonio
dc.contributor.advisor.none.fl_str_mv Navarro Rubiano, Margarita
Castellanos Domínguez, Yeny Zulay
dc.contributor.author.none.fl_str_mv Zúniga Sierra, Eduardo Antonio
dc.contributor.cvlac.spa.fl_str_mv Navarro Rubiano, Margarita [0001674101]
Castellanos Domínguez, Yeny Zulay [0001363740]
dc.contributor.orcid.spa.fl_str_mv Castellanos Domínguez, Yeny Zulay [0000-0001-5881-1998]
dc.contributor.researchgate.spa.fl_str_mv Castellanos Domínguez, Yeny Zulay [Yeny-Castellanos-2]
dc.contributor.apolounab.spa.fl_str_mv Navarro Rubiano, Margarita [margarita-navarro-rubiano]
Castellanos Domínguez, Yeny Zulay [yeny-zulay-castellanos-domínguez]
dc.subject.keywords.spa.fl_str_mv Gynecology
Obstetrics
Medical sciences
Health sciences
Colombia
Contraception
Long-acting reversible contraception
Postpartum period
Intrauterine devices
Family development planning
Birth control
Copper intrauterine contraceptives
Postpartum period
topic Gynecology
Obstetrics
Medical sciences
Health sciences
Colombia
Contraception
Long-acting reversible contraception
Postpartum period
Intrauterine devices
Family development planning
Birth control
Copper intrauterine contraceptives
Postpartum period
Ginecología
Obstetricia
Ciencias médicas
Control natal
Anticonceptivos intrauterinos de cobre
Periodo posparto
Anticoncepción
Periodo posparto
Anticoncepción reversible de larga duración
Dispositivos intrauterinos
Planificación familiar
Colombia
Ciencias de la salud
dc.subject.lemb.spa.fl_str_mv Ginecología
Obstetricia
Ciencias médicas
Control natal
Anticonceptivos intrauterinos de cobre
Periodo posparto
dc.subject.proposal.spa.fl_str_mv Anticoncepción
Periodo posparto
Anticoncepción reversible de larga duración
Dispositivos intrauterinos
Planificación familiar
Colombia
Ciencias de la salud
description El objetivo principal de este estudio es conocer el impacto del uso de un medio audiovisual en la percepción sobre el uso del dispositivo intrauterino tipo T de cobre (DIU-Cu) en mujeres mayores de 18 años que se encuentren en las primeras 48 horas de parto vaginal en el hospital Local del Norte, se seleccionaron y encuestaron un total de 233 mujeres entre 18-44 años, encontrando que los resultados de este estudio sugieren que el uso de un medio audiovisual puede ser una estrategia efectiva para mejorar la percepción y el conocimiento del DIU-Cu como método anticonceptivo en mujeres en puerperio inmediato de parto vaginal.
publishDate 2023
dc.date.accessioned.none.fl_str_mv 2023-08-09T18:34:55Z
dc.date.available.none.fl_str_mv 2023-08-09T18:34:55Z
dc.date.issued.none.fl_str_mv 2023-08-04
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/masterThesis
dc.type.local.spa.fl_str_mv Tesis
dc.type.hasversion.none.fl_str_mv info:eu-repo/semantics/acceptedVersion
dc.type.redcol.none.fl_str_mv http://purl.org/redcol/resource_type/TM
status_str acceptedVersion
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/20.500.12749/21121
dc.identifier.instname.spa.fl_str_mv instname:Universidad Autónoma de Bucaramanga - UNAB
dc.identifier.reponame.spa.fl_str_mv reponame:Repositorio Institucional UNAB
dc.identifier.repourl.spa.fl_str_mv repourl:https://repository.unab.edu.co
url http://hdl.handle.net/20.500.12749/21121
identifier_str_mv instname:Universidad Autónoma de Bucaramanga - UNAB
reponame:Repositorio Institucional UNAB
repourl:https://repository.unab.edu.co
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.references.spa.fl_str_mv United Nations. Contraceptive Use by Method 2019. Contraceptive Use by Method 2019. 2019
Silva-Filho AL da, Lira J, Rocha ALL, Ferreira MCF, Lamaita RM, Cândido EB, et al. Non-hormonal and hormonal intrauterine contraception: survey of patients’ perceptions in four Latin American countries. European Journal of Contraception and Reproductive Health Care. 2016;21(3):213–9.
Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception. Obstetrics and gynecology. 2016 Aug 1;128(2):e32–7.
Ministerio de Salud y Protección Social. Encuesta Nacional de Demografía y Salud Colombia 2015. Resumen ejecutivo. Semarnat. 2017;1–96.
Ministerio de salud y proteccion social, profamilia. Encuesta Nacional de Demografía y Salud Encuesta Nacional de Demografía y Salud Componente de Salud Sexual y Salud Reproductiva. 2015.
WHO. Estrategias para la Programación de la Planificación Familiar Posparto. Geneva: World Health Organization; 2014. p. 58.
Williams HR, Goad L, Treloar M, Ryken K, Mejia R, Zimmerman MB, et al. Confidence and readiness to discuss, plan and implement postpartum contraception during prenatal care versus after delivery. J Obstet Gynaecol (Lahore). 2019;39(7):941–7.
WHO. Report of a WHO Technical Consultation on Birth Spacing. Report of a WHO Technical Consultation on Birth Spacing. 2005;13(6):1–44.
Who, Unicef, Unfpa TWBank. Maternal Mortality in 2005: estimates developed by WHO, UNICEF, UNFPA and The World Bank. Bull World Health Organ. 2007;79:657–64.
Saeed GA, Fakhar S, Rahim F, Tabassum S. Change in trend of contraceptive uptake - effect of educational leaflets and counseling. Contraception. 2008;77(5):377–81.
Canning D, Shah IH, Pearson E, Pradhan E, Karra M, Senderowicz L, et al. Institutionalizing postpartum intrauterine device (IUD) services in Sri Lanka, Tanzania, and Nepal: study protocol for a cluster-randomized stepped-wedge trial. BMC Pregnancy Childbirth. 2016 Dec 21;16(1):362.
Gómez Sánchez PI. Anticoncepción. Pasado, presente y futuro. Bogotá: Universidad Nacional Sede Bogotá; 2010. 43–45 p.
Alkema L, Kantorova V, Menozzi C, Biddlecom A. National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: A systematic and comprehensive analysis. The Lancet. 2013;381(9878):1642–52.
Ahmed S, Choi Y, Rimon JG, Alzouma S, Gichangi P, Guiella G, et al. Trends in contraceptive prevalence rates in sub-Saharan Africa since the 2012 London Summit on Family Planning: results from repeated cross-sectional surveys. Lancet Glob Health. 2019;7(7):e904–11.
United Nations. World Family Planning 2022 Meeting the changing needs for family planning: Contraceptive use by age and method. Nueva York; 2022.
Moore Z, Pfitzer A, Gubin R, Charurat E, Elliott L, Croft T. Missed opportunities for family planning: An analysis of pregnancy risk and contraceptive method use among postpartum women in 21 low- and middle-income countries. Contraception. 2015;92(1):31–9.
Keogh SC, Urassa M, Kumogola Y, Kalongoji S, Kimaro D, Zaba B. Postpartum Contraception in Northern Tanzania: Patterns of Use, Relationship to Antenatal Intentions, and Impact of Antenatal Counseling. Stud Fam Plann. 2015;46(4):405–22.
Zimmerman LA, Yi Y, Yihdego M, Abrha S, Shiferaw S, Seme A, et al. Effect of integrating maternal health services and family planning services on postpartum family planning behavior in Ethiopia: Results from a longitudinal survey. BMC Public Health. 2019;19(1):1–9.
Dev R, Kohler P, Feder M, Unger JA, Woods NF, Drake AL. A systematic review and meta-analysis of postpartum contraceptive use among women in low- And middle-income countries. Reprod Health. 2019;16(1):1–17.
Vernon R. Meeting the Family Postpartum Planning Women. Stud Fam Plann. 2012;40(3):235–45.
Cwiak C, Gellasch T, Zieman M. Peripartum contraceptive attitudes and practices. Contraception. 2004;70(5):383–6.
DEHLENDORF C, KRAJEWSKI C, BORRERO S. 14. Contraceptive Counseling: Best Practices to Ensure Quality Communication and Enable Effective Contraceptive Use. Clin Obstet Gynecol. 2014;57(4):659–73.
Nicolaides KH. Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy. The American College of Obstetricians and Gynecologist. 2017;701(698):1–4.
MINISTERIO DE SALUD Y PROTECCIÓN SOCIAL. RESOLUCIÓN NÚMERO 3280 DE 2018. 2018.
Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception. Obstetrics and gynecology. 2016 Aug 1;128(2):e32–7.
Dehlendorf C, Fitzpatrick J, Steinauer J, Swiader L, Grumbach K, Hall C, et al. Development and field testing of a decision support tool to facilitate shared decision making in contraceptive counseling. Patient Educ Couns. 2017;100(7):1374–81.
Cunningham, F. Gary ; Leveno, Kenneth J.; Bloom, Steven L.; Dashe, Jodi S.; Hoffman, Barbara L.; Casey, Brian M.; Spong CY. Williams OBSTETRICIA. McGraw Hill Education; 2019.
WHO. WHO Technical Consultation on Postpartum and Postnatal Care. 2010. p. 65.
Moore AM, Dauphinee LA. Reasons U . S . Women Have Abortions : Quantitative and Qualitative Perspectives. Perspect Sex Reprod Health. 2005;37(3):110–8.
Anne Nordal Broen, M.D.*, Torbjfrn Moum PhD, Anne Sejersted Bfdtker, M.D., O ̈ ivind Ekeberg, M.D. PhD. Reasons for induced abortion and their relation to women ’ s emotional distress : a prospective , two-year follow-up study. Gen Hosp Psychiatry. 2005;27(1):36–43.
SOBER S, SCHREIBER CA. Postpartum Contraception. Clin Obstet Gynecol. 2014;57(4):763–76.
USAID, Johns Hopkins Bloomberg School of Public Health and Center For Communication Program, World Health Organization. Family Planning. A Global Handbook for Providers. 2018. 2018.
Lester F, Kakaire O, Byamugisha J, Averbach S, Fortin J, Maurer R, et al. Intracesarean insertion of the Copper T380A versus 6 weeks postcesarean: A randomized clinical trial. Contraception. 2015;91(3):198–203.
WHO. Implementation Guide For The Medical Eligibility Criteria For Contraceptive Use And Selected Practice Recommendations For Contraceptive Use Guidelines. 2018.
Report MW. U . S . Medical Eligibility Criteria for Contraceptive Use , 2016. Vol. 65. 2016.
WHO. The ABC’s of Family Planning. 2010.
Cleland J, Bernstein S, Ezeh A, Faundes A, Glasier A, Innis J. Sexual and Reproductive Health 3 Family planning : the unfi nished agenda. 2006;368.
Titilope Oduyebo, MD, MPH; Lauren B. Zapata, PhD; Maegan E. Boutot, MS; Naomi K. Tepper, MD M, Kathryn M. Curtis, PhD; Denise V. D’Angelo, MPH; Polly A. Marchbanks, PhD; Maura K. Whiteman P, Marchbanks PA, Whiteman MK. Factors associated with postpartum use of long-acting reversible contraception. The American Journal of Obstetrics & Gynecology. 2019;221(1):43.e1-43.e11.
Oddens BJ. DETERMINANTS OF CONTRACEPTIVE USE AMONG WOMEN OF REPRODUCTIVE AGE IN GREAT BRITAIN AND GERMANY II : PSYCHOLOGICAL FACTORS. J biosoc Sci. 1997;437–70.
Belfield T, Ffsrh H. Best Practice & Research Clinical Obstetrics and Gynaecology Principles of contraceptive care : choice , acceptability and access. Best Pract Res Clin Obstet Gynaecol. 2009;23(2):177–85.
Wellings K, Zhihong Z, Krentel A, Barrett G, Glasier A. Attitudes towards long- acting reversible methods of contraception in general practice in the UK. 2007;76:208–14.
Hersh AR, Muñoz LF, Rincón M, Alvarez C, Tolosa JE, Moreno DJ, et al. Video compared to conversational contraceptive counseling during labor and maternity hospitalization in Colombia: A randomized trial. Contraception. 2018 Sep;98(3):210–4.
Hebert LE, Hill BJ, Quinn M, Holl JL, Whitaker AK, Gilliam ML. Mobile contraceptive application use in a clinical setting in addition to standard contraceptive counseling: A randomized controlled trial. Contraception. 2018;98(4):281–7.
Lohr PA, Aiken ARA, Forsyth T, Trussell J. Telephone or integrated contraception counselling before abortion: Impact on method choice and receipt. BMJ Sex Reprod Health. 2018;44(2):114–21.
Koo HP, Wilson EK, Minnis AM. A Computerized Family Planning Counseling Aid: A Pilot Study Evaluation of Smart Choices. Perspect Sex Reprod Health. 2017;49(1):45–53.
Sapkota S, Rajbhandary R, Lohani S. The Impact of Balanced Counseling on Contraceptive Method Choice and Determinants of Long Acting and Reversible Contraceptive Continuation in Nepal. Matern Child Health J. 2017;21(9):1713–23.
Sridhar A, Chen A, Forbes ER, Glik D. Mobile application for information on reversible contraception: A randomized controlled trial. Am J Obstet Gynecol. 2015;212(6):774.e1-774.e7.
George T, DeCristofaro C, Dumas B, Murphy P. Shared Decision Aids: Increasing Patient Acceptance of Long-Acting Reversible Contraception. Healthcare. 2015;3(2):205–18.
Farrokh-Eslamlou H, Aghlmand S, Eslami M, Homer CSE. Impact of the World Health Organization’s decision-making tool for family planning clients and providers on the quality of family planning services in Iran. Journal of Family Planning and Reproductive Health Care. 2014;40(2):89–95.
Castaño PM, Bynum JY, Andrés R, Lara M, Westhoff C. Effect of daily text messages on oral contraceptive continuation: A randomized controlled trial. Obstetrics and Gynecology. 2012;119(1):14–20.
Coleman-Minahan K, Potter JE. Quality of postpartum contraceptive counseling and changes in contraceptive method preferences. Contraception. 2019;100(6):492–7.
Taub RL, Jensen JT. Advances in contraception: new options for postpartum women. Expert Opin Pharmacother. 2017;18(7):677–88.
Delvoye P, Demaegd M, Uwayitu-Nyampeta, Robyn C. Serum prolactin, gonadotropins, and estradiol in menstruating and amenorrheic mothers during two years’ lactation. Am J Obstet Gynecol. 1978;130(6):635–9.
Van der Wijden C, Brown J, Kleijnen J. Lactational amenorrhea for family planning. Cochrane Database of Systematic Reviews. 2003;(4).
Meng K, Hu X, Peng X, Zhang Z. Incidence of venous thromboembolism during pregnancy and the puerperium: A systematic review and meta-analysis. Journal of Maternal-Fetal and Neonatal Medicine. 2015;28(3):245–53.
Poulter NR, Meirik O. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives: Results of an international multicenter, case-control study. Contraception. 1998;57(5 SUPPL.):315–24.
Simmons KB, Edelman AB, Li H, Yanit KE, Jensen JT. Personalized contraceptive assistance and uptake of long-acting, reversible contraceptives by postpartum women: A randomized, controlled trial. Contraception. 2013;88(1):45–51.
Fda. NEXPLANON (etonogestrel implant) IMPLANON (etonogestrel implant).
FECOLSOG. FECOLSOG. 2017. Anticoncepción Post Evento de Morbilidad Materna Extrema Anticoncepción Post Evento de Morbilidad. Available from: https://fecolsog.org/articulos-noticias/anticoncepcion-post-evento-de- morbilidad-materna-extrema/
Fda. JADELLE (levonorgestrel implants) for subdermal use.
UNDP/UNFPA/WHO/World Bank Special Programme of Research D and RT in HR (HRP). External evaluation 2003–2007; Long-term safety and effectiveness of copper-releasing intrauterine devices: a case-study. 2008.
Reversible L acting, Devices I. Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices. 2018;131(735):130–9.
fda, cder. ParaGard ® T380A INTRAUTERINE COPPER CONTRACEPTIVE PRESCRIBING INFORMATION ParaGard ® T 380A Intrauterine Copper Contraceptive.
De D, Cruz A, Arteaga M, Castillo L, Tovalin H. Blood copper levels in Mexican users of the T380A IUD. Contraception. 2005;72(2):122–5.
Stanford JB, Mikolajczyk RT. Mechanisms of action of intrauterine devices: Update and estimation of postfertilization effects. Vol. 187, American Journal of Obstetrics and Gynecology. Mosby Inc.; 2002. p. 1699–708.
Heinemann K, Reed S, Moehner S, Do Minh T. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: The European Active Surveillance Study for Intrauterine Devices. Contraception. 2015 Apr 1;91(4):280–3.
Cwiak C, Cordes S. Postpartum intrauterine device placement: a patient- friendly option. Contracept Reprod Med. 2018;3(1):3–7.
Secura, Gina M., PhD, MPH; Allsworth, Jenifer E., PhD; Madden, Tessa, MD, MPH; Mullersman, Jennifer L., BSN; Peipert, Jeffrey F., MD P. The Contraceptive CHOICE Project: Reducing Barriers to LongActing Reversible Contraception. Am J Obstet Gynecol. 2010;203(2):115.
Aoun J, Dines VA, Gomez-lobo V, Stovall DW, Nelson CB. Effects of Age , Parity , and Device Type on Complications and Discontinuation of Intrauterine Devices. Obstetrics & Gynecology. 2014;123(3):585–92.
Berenson AB, Tan A, Hirth JM WGS. Complications and Continuation of Intrauterine Device Use Among Commercially Insured Teenagers. Obstetrics & Gynecology. 2014;121(5):951–8.
Berenson AB, Tan A, Hirth JM WGS. Complications and Continuation of Intrauterine Device Use Among Commercially Insured Teenagers. Obstetrics & Gynecology. 2014;121(5):951–8.
Luchowski AT, Anderson BL, Power ML, Raglan GB, Espey E, Schulkin J. Obstetrician – Gynecologists and contraception : practice and opinions about the use of IUDs in nulliparous women , adolescents and other. Contraception. 2014;89(6):572–7.
Teal SB, Romer SE, Lisa M, Peters MG, Kaplan DW. Insertion Characteristics of Intrauterine Devices in Adolescents and Young Women: Success, Ancillary Measures, and Complications. Am J Obstet Gynecol. 2015;213(4):515.e1-5.
Cleland K, Raymond EG, Westley E, Trussell J. Emergency contraception review: Evidence-based recommendations for clinicians. Vol. 57, Clinical Obstetrics and Gynecology. Lippincott Williams and Wilkins; 2014. p. 741–50.
Bahamondes L, Bahamondes MV, Shulman LP. Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods. Hum Reprod Update. 2015;0(0):1–12.
Cortessis VK, Barrett M, BrownWade N, Enebish T, Perrigo JL, Tobin J, et al. Intrauterine device use and cervical cancer risk: A systematic review and meta-analysis. In: Obstetrics and Gynecology. Lippincott Williams and Wilkins; 2017. p. 1226–36.
Gómez Sanchéz PI. Anticoncepcion: Pasado, presente y futuro. Bogotá: Univesidad Nacional de Colombia; 2010.
Goldthwaite LM, Cahill EP, Voedisch AJ, Blumenthal PD. Postpartum intrauterine devices: clinical and programmatic review. Am J Obstet Gynecol. 2018;219(3):235–41.
Chen BA, Reeves MF, Hayes JL, Hohmann HL, Perriera LK, Creinin MD. Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: A randomized controlled trial. Obstetrics and Gynecology. 2010;116(5):1079–87.
Whitaker AK, Endres LK, Mistretta SQ, Gilliam ML. Postplacental insertion of the levonorgestrel intrauterine device after cesarean delivery vs. delayed insertion: A randomized controlled trial. Contraception. 2014;89(6):534–9.
Sonalkar S, Kapp N. Intrauterine device insertion in the postpartum period: A systematic review. European Journal of Contraception and Reproductive Health Care. 2015;20(1):4–18.
Farley TMM, Rowe PJ, Meirik O, Rosenberg MJ, Chen JH. Intrauterine devices and pelvic inflammatory disease: an international perspective. The Lancet. 1992 Mar;339(8796):785–8.
Toivonen J. Intrauterine Contraceptive Device and Pelvic Inflammatory Disease. Ann Med. 1993 Jan 8;25(2):171–3.
Borda MR, Winfrey W, McKaig C. Return to sexual activity and modern family planning use in the extended postpartum period: an analysis of findings from seventeen countries. Afr J Reprod Health. 2010;14(4 Spec no.):72–9.
Branum AM, Jones J. Trends in long-acting reversible contraception use among U.S. women aged 15-44. NCHS Data Brief. 2015;(188):1–8.
Zerden ML, Tang JH, Stuart GS, Norton DR, Verbiest SB, Brody S. Barriers to Receiving Long-acting Reversible Contraception in the Postpartum Period. Women’s Health Issues. 2015;25(6):616–21.
Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, et al. Effectiveness of long-acting reversible contraception. Obstet Gynecol Surv. 2012;67(9):552–3.
Cleland J, Ali M, Benova L, Daniele M. The promotion of intrauterine contraception in low- and middle-income countries: a narrative review. Contraception. 2017;95(6):519–28.
Pradhan E, Canning D, Shah IH, Puri M, Pearson E, Thapa K, et al. Integrating postpartum contraceptive counseling and IUD insertion services into maternity care in Nepal: Results from stepped-wedge randomized controlled trial. Reprod Health. 2019;16(1):1–15.
Zapata, Lauren B., PhD; Murtaza, Sarah, MPH; Whiteman, Maura K., PhD; Jamieson, Denise J., MD; Robbins, Cheryl L., PhD; Marchbanks, Polly A., PhD; D’Angelo, Denise V, MPH; Curtis, Kathryn M. PhD. Contraceptive counseling and postpartum contraceptive use. Am J Obstet Gynecol. 2015;212(2):171.
Hernandez LE, Sappenfield WM, Goodman D, Pooler J. Is effective contraceptive use conceived prenatally in Florida? the association between prenatal contraceptive counseling and postpartum contraceptive use. Matern Child Health J. 2012;16(2):423–9.
Harper KD, Loper AC, Louison LM, Morse JE. Stage-based implementation of immediate postpartum long-acting reversible contraception using a reproductive justice framework. Am J Obstet Gynecol. 2020 Apr 1;222(4):S893–905.
George IE Eluwa, Ronke Atamewalen, Kingsley Odogwu BA. Success Providing Postpartum Intrauterine Devices in. Glob Health Sci Pract. 2016;4(2):1–6.
Pleah T, Hyjazi Y, Austin S, Diallo A, Dao B, Waxman R, et al. Increasing use of postpartum family planning and the postpartum IUD: Early experiences in west and central Africa. In: Global Health Science and Practice. Johns Hopkins University Press; 2016. p. S140–52.
Pfitzer A, Mackenzie D, Blanchard H, Hyjazi Y, Kumar S, Lisanework Kassa S, et al. A facility birth can be the time to start family planning: Postpartum intrauterine device experiences from six countries. International Journal of Gynecology & Obstetrics. 2015 Jun 1;130(S2):S54–61.
Huang Y, Merkatz R, Zhu H, Roberts K, Sitruk-Ware R, Cheng L. The free perinatal/postpartum contraceptive services project for migrant women in Shanghai: Effects on the incidence of unintended pregnancy. Contraception. 2014 Jun 1;89(6):521–7.
Ortiz-González KM, Benabe E, Rivera-Rosa E, Negrón I, Romaguera J. Knowledge and choices of postpartum contraception among pregnant teens. P R Health Sci J. 2014;33(3):117–21.
Lopez LM, Hiller JE, Grimes DA, Chen M. Education for contraceptive use by women after childbirth. Cochrane Database of Systematic Reviews. 2012;(8).
Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception. Obstetrics and gynecology. 2016 Aug;128(2):e32- 7.
Huang P, Yao J, Liu X, Luo B. Individualized intervention to improve rates of exclusive breastfeeding. Medicine. 2019 Nov;98(47):e17822.
Torres-Cantero AM, Álvarez León EE, Morán-Sánchez I, San Lázaro Campillo I, Bernal Morell E, Hernández Pereña M, et al. El impacto de la pandemia de COVID-19 sobre la salud. Informe SESPAS 2022. Gac Sanit. 2022;36:S4–12.
Perez T, Perez RL, Roman J. Conducting Clinical Research in the Era of Covid-19. Am J Med Sci. 2020 Sep;360(3):213–5.
Almufleh A, Joseph J. The time is now: role of pragmatic clinical trials in guiding response to global pandemics. Trials. 2021 Dec 24;22(1):229.
Bierer BE, White SA, Barnes JM, Gelinas L. Ethical Challenges in Clinical Research During the COVID-19 Pandemic. J Bioeth Inq. 2020 Dec 9;17(4):717–22.
Meyer MN, Gelinas L, Bierer BE, Hull SC, Joffe S, Magnus D, et al. An ethics framework for consolidating and prioritizing COVID-19 clinical trials. Clinical Trials. 2021 Apr 2;18(2):226–33.
Madariaga A, Kasherman L, Karakasis K, Degendorfer P, Heesters AM, Xu W, et al. Optimizing clinical research procedures in public health emergencies. Med Res Rev. 2021 Mar 11;41(2):725–38.
dc.relation.uriapolo.spa.fl_str_mv https://apolo.unab.edu.co/en/persons/margarita-navarro-rubiano
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.local.spa.fl_str_mv Abierto (Texto Completo)
dc.rights.creativecommons.*.fl_str_mv Atribución-NoComercial-SinDerivadas 2.5 Colombia
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
Abierto (Texto Completo)
Atribución-NoComercial-SinDerivadas 2.5 Colombia
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.coverage.spatial.spa.fl_str_mv Bucaramanga (Santander, Colombia)
dc.coverage.temporal.spa.fl_str_mv Enero de 2021 a mayo de 2022
dc.coverage.campus.spa.fl_str_mv UNAB Campus Bucaramanga
dc.publisher.grantor.spa.fl_str_mv Universidad Autónoma de Bucaramanga UNAB
dc.publisher.faculty.spa.fl_str_mv Facultad Ciencias de la Salud
dc.publisher.program.spa.fl_str_mv Especialización en Ginecología y Obstetricia
institution Universidad Autónoma de Bucaramanga - UNAB
bitstream.url.fl_str_mv https://repository.unab.edu.co/bitstream/20.500.12749/21121/1/2023_Tesis_Eduardo_Zu%c3%b1iga.pdf
https://repository.unab.edu.co/bitstream/20.500.12749/21121/5/2023_Licencia_Eduardo_Zu%c3%b1iga.pdf
https://repository.unab.edu.co/bitstream/20.500.12749/21121/4/license.txt
https://repository.unab.edu.co/bitstream/20.500.12749/21121/6/2023_Tesis_Eduardo_Zu%c3%b1iga.pdf.jpg
https://repository.unab.edu.co/bitstream/20.500.12749/21121/7/2023_Licencia_Eduardo_Zu%c3%b1iga.pdf.jpg
bitstream.checksum.fl_str_mv 0b4e4a6bbf9e200638dbe2bc4e6f3787
8d29ccd276c0e2f8b51bdcf3cdc6dbd5
3755c0cfdb77e29f2b9125d7a45dd316
61ddc5db993ca8ff82724a83baa2ab1c
07a9151e0a8c49f685ebc5cdda1a6a95
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional | Universidad Autónoma de Bucaramanga - UNAB
repository.mail.fl_str_mv repositorio@unab.edu.co
_version_ 1814277536884981760
spelling Navarro Rubiano, Margarita8b51f90f-5271-4006-9de1-772d1d271dedCastellanos Domínguez, Yeny Zulay54631a53-af99-48cb-b907-3894879a1e49Zúniga Sierra, Eduardo Antonioef93fd65-67ce-42ca-b5e4-549db7780586Navarro Rubiano, Margarita [0001674101]Castellanos Domínguez, Yeny Zulay [0001363740]Castellanos Domínguez, Yeny Zulay [0000-0001-5881-1998]Castellanos Domínguez, Yeny Zulay [Yeny-Castellanos-2]Navarro Rubiano, Margarita [margarita-navarro-rubiano]Castellanos Domínguez, Yeny Zulay [yeny-zulay-castellanos-domínguez]Bucaramanga (Santander, Colombia)Enero de 2021 a mayo de 2022UNAB Campus Bucaramanga2023-08-09T18:34:55Z2023-08-09T18:34:55Z2023-08-04http://hdl.handle.net/20.500.12749/21121instname:Universidad Autónoma de Bucaramanga - UNABreponame:Repositorio Institucional UNABrepourl:https://repository.unab.edu.coEl objetivo principal de este estudio es conocer el impacto del uso de un medio audiovisual en la percepción sobre el uso del dispositivo intrauterino tipo T de cobre (DIU-Cu) en mujeres mayores de 18 años que se encuentren en las primeras 48 horas de parto vaginal en el hospital Local del Norte, se seleccionaron y encuestaron un total de 233 mujeres entre 18-44 años, encontrando que los resultados de este estudio sugieren que el uso de un medio audiovisual puede ser una estrategia efectiva para mejorar la percepción y el conocimiento del DIU-Cu como método anticonceptivo en mujeres en puerperio inmediato de parto vaginal.1. RESUMEN......................................................................................................................................... 4 2. PLANTEAMIENTO DEL PROBLEMA DE INVESTIGACIÓN Y JUSTIFICACIÓN............................... 5 2.1 Pregunta de investigación........................................................................................................... 10 3. MARCO TEÓRICO ............................................................................................................................ 10 3.1 Definiciones ................................................................................................................................... 10 3.2. Intervenciones educativas para promover la planificación familiar .................................... 12 3.3 Métodos disponibles en la planificación posparto .................................................................. 16 3.4 Importancia del DIU posparto comparado con otros métodos de planificación................. 21 3.5 Historia de los Dispositivos Intrauterinos.................................................................................. 22 3.6 Técnica de inserción del DIU T de cobre ................................................................................... 23 3.7 Momento de la inserción ............................................................................................................. 24 3.8 Complicaciones y tasas de expulsión del DIU en el posparto ................................................ 26 3.9 Seguimiento posterior a inserción del dispositivo intrauterino T de cobre ......................... 26 3.10 Contraindicaciones para el uso de dispositivo intrauterino T de cobre en el posparto.... 27 4. ESTADO DEL ARTE ........................................................................................................................... 28 5. OBJETIVOS ........................................................................................................................................ 37 5.1 General ........................................................................................................................................... 37 5.2 Específicos ..................................................................................................................................... 38 6.METODOLOGÍA................................................................................................................................. 38 6.1 Tipo y diseño de estudio ............................................................................................................. 38 6.2 Hipótesis......................................................................................................................................... 38 6.3 Ubicación espacio temporal ....................................................................................................... 38 6.4 Población blanco........................................................................................................................... 39 6.5 Criterios de selección................................................................................................................... 39 6.6 Tamaño de la muestra y muestreo............................................................................................ 39 6.7 Intervención (Medio audiovisual)............................................................................................... 40 6.8 Instrumento de recolección ....................................................................................................... 40 6.9 Variables......................................................................................................................................... 41 6.10 Procedimiento del estudio........................................................................................................ 41 6.11 Plan de análisis........................................................................................................................... 42 7. CONTROL DE SESGO...................................................................................................................... 42 8.CONSIDERACIONES ÉTICAS............................................................................................................ 43 9. RESULTADOS .................................................................................................................................. 44 9.1 Análisis univariado ...................................................................................................................... 44 9.2 Análisis de la intervención.......................................................................................................... 49 9.3 Análisis bivariado......................................................................................................................... 55 9.4 Análisis multivariado ................................................................................................................... 61 10. DISCUSIÓN .................................................................................................................................... 62 11. CONCLUSIONES ........................................................................................................................... 66 12. FORTALEZAS Y LIMITACIONES ................................................................................................... 67 13. APORTES DEL ESTUDIO............................................................................................................... 68 14. REFERENCIAS ............................................................................................................................... 70 15. ANEXOS......................................................................................................................................... 79EspecializaciónThe main objective of this study is to know the impact of the use of an audiovisual media on the perception of the use of the copper intrauterine device in women over 18 years of age who are in the first 48 hours of vaginal delivery at the Local del Norte hospital, a total of 233 women between 18-44 years of age were selected and surveyed, finding that the results of this study suggest that the use of an audiovisual media can be an effective strategy to improve perception and knowledge of the copper IUD as a contraceptive method in women in the immediate postpartum period after vaginal delivery.Modalidad Presencialapplication/pdfspahttp://creativecommons.org/licenses/by-nc-nd/2.5/co/Abierto (Texto Completo)Atribución-NoComercial-SinDerivadas 2.5 Colombiahttp://purl.org/coar/access_right/c_abf2Impacto de un medio audiovisual en la percepción del dispositivo intrauterino tipo T de cobre en el puerperio inmediato en mujeres mayores de edad en el Hospital Local del Norte, ColombiaImpact of an audiovisual media on the perception of the copper intrauterine device in the immediate puerperium in women of legal age at the Local del Norte hospital, ColombiaEspecialista en Ginecología y ObstetriciaUniversidad Autónoma de Bucaramanga UNABFacultad Ciencias de la SaludEspecialización en Ginecología y Obstetriciainfo:eu-repo/semantics/masterThesisTesisinfo:eu-repo/semantics/acceptedVersionhttp://purl.org/redcol/resource_type/TMGynecologyObstetricsMedical sciencesHealth sciencesColombiaContraceptionLong-acting reversible contraceptionPostpartum periodIntrauterine devicesFamily development planningBirth controlCopper intrauterine contraceptivesPostpartum periodGinecologíaObstetriciaCiencias médicasControl natalAnticonceptivos intrauterinos de cobrePeriodo pospartoAnticoncepciónPeriodo pospartoAnticoncepción reversible de larga duraciónDispositivos intrauterinosPlanificación familiarColombiaCiencias de la saludUnited Nations. Contraceptive Use by Method 2019. Contraceptive Use by Method 2019. 2019Silva-Filho AL da, Lira J, Rocha ALL, Ferreira MCF, Lamaita RM, Cândido EB, et al. Non-hormonal and hormonal intrauterine contraception: survey of patients’ perceptions in four Latin American countries. European Journal of Contraception and Reproductive Health Care. 2016;21(3):213–9.Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception. Obstetrics and gynecology. 2016 Aug 1;128(2):e32–7.Ministerio de Salud y Protección Social. Encuesta Nacional de Demografía y Salud Colombia 2015. Resumen ejecutivo. Semarnat. 2017;1–96.Ministerio de salud y proteccion social, profamilia. Encuesta Nacional de Demografía y Salud Encuesta Nacional de Demografía y Salud Componente de Salud Sexual y Salud Reproductiva. 2015.WHO. Estrategias para la Programación de la Planificación Familiar Posparto. Geneva: World Health Organization; 2014. p. 58.Williams HR, Goad L, Treloar M, Ryken K, Mejia R, Zimmerman MB, et al. Confidence and readiness to discuss, plan and implement postpartum contraception during prenatal care versus after delivery. J Obstet Gynaecol (Lahore). 2019;39(7):941–7.WHO. Report of a WHO Technical Consultation on Birth Spacing. Report of a WHO Technical Consultation on Birth Spacing. 2005;13(6):1–44.Who, Unicef, Unfpa TWBank. Maternal Mortality in 2005: estimates developed by WHO, UNICEF, UNFPA and The World Bank. Bull World Health Organ. 2007;79:657–64.Saeed GA, Fakhar S, Rahim F, Tabassum S. Change in trend of contraceptive uptake - effect of educational leaflets and counseling. Contraception. 2008;77(5):377–81.Canning D, Shah IH, Pearson E, Pradhan E, Karra M, Senderowicz L, et al. Institutionalizing postpartum intrauterine device (IUD) services in Sri Lanka, Tanzania, and Nepal: study protocol for a cluster-randomized stepped-wedge trial. BMC Pregnancy Childbirth. 2016 Dec 21;16(1):362.Gómez Sánchez PI. Anticoncepción. Pasado, presente y futuro. Bogotá: Universidad Nacional Sede Bogotá; 2010. 43–45 p.Alkema L, Kantorova V, Menozzi C, Biddlecom A. National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: A systematic and comprehensive analysis. The Lancet. 2013;381(9878):1642–52.Ahmed S, Choi Y, Rimon JG, Alzouma S, Gichangi P, Guiella G, et al. Trends in contraceptive prevalence rates in sub-Saharan Africa since the 2012 London Summit on Family Planning: results from repeated cross-sectional surveys. Lancet Glob Health. 2019;7(7):e904–11.United Nations. World Family Planning 2022 Meeting the changing needs for family planning: Contraceptive use by age and method. Nueva York; 2022.Moore Z, Pfitzer A, Gubin R, Charurat E, Elliott L, Croft T. Missed opportunities for family planning: An analysis of pregnancy risk and contraceptive method use among postpartum women in 21 low- and middle-income countries. Contraception. 2015;92(1):31–9.Keogh SC, Urassa M, Kumogola Y, Kalongoji S, Kimaro D, Zaba B. Postpartum Contraception in Northern Tanzania: Patterns of Use, Relationship to Antenatal Intentions, and Impact of Antenatal Counseling. Stud Fam Plann. 2015;46(4):405–22.Zimmerman LA, Yi Y, Yihdego M, Abrha S, Shiferaw S, Seme A, et al. Effect of integrating maternal health services and family planning services on postpartum family planning behavior in Ethiopia: Results from a longitudinal survey. BMC Public Health. 2019;19(1):1–9.Dev R, Kohler P, Feder M, Unger JA, Woods NF, Drake AL. A systematic review and meta-analysis of postpartum contraceptive use among women in low- And middle-income countries. Reprod Health. 2019;16(1):1–17.Vernon R. Meeting the Family Postpartum Planning Women. Stud Fam Plann. 2012;40(3):235–45.Cwiak C, Gellasch T, Zieman M. Peripartum contraceptive attitudes and practices. Contraception. 2004;70(5):383–6.DEHLENDORF C, KRAJEWSKI C, BORRERO S. 14. Contraceptive Counseling: Best Practices to Ensure Quality Communication and Enable Effective Contraceptive Use. Clin Obstet Gynecol. 2014;57(4):659–73.Nicolaides KH. Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy. The American College of Obstetricians and Gynecologist. 2017;701(698):1–4.MINISTERIO DE SALUD Y PROTECCIÓN SOCIAL. RESOLUCIÓN NÚMERO 3280 DE 2018. 2018.Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception. Obstetrics and gynecology. 2016 Aug 1;128(2):e32–7.Dehlendorf C, Fitzpatrick J, Steinauer J, Swiader L, Grumbach K, Hall C, et al. Development and field testing of a decision support tool to facilitate shared decision making in contraceptive counseling. Patient Educ Couns. 2017;100(7):1374–81.Cunningham, F. Gary ; Leveno, Kenneth J.; Bloom, Steven L.; Dashe, Jodi S.; Hoffman, Barbara L.; Casey, Brian M.; Spong CY. Williams OBSTETRICIA. McGraw Hill Education; 2019.WHO. WHO Technical Consultation on Postpartum and Postnatal Care. 2010. p. 65.Moore AM, Dauphinee LA. Reasons U . S . Women Have Abortions : Quantitative and Qualitative Perspectives. Perspect Sex Reprod Health. 2005;37(3):110–8.Anne Nordal Broen, M.D.*, Torbjfrn Moum PhD, Anne Sejersted Bfdtker, M.D., O ̈ ivind Ekeberg, M.D. PhD. Reasons for induced abortion and their relation to women ’ s emotional distress : a prospective , two-year follow-up study. Gen Hosp Psychiatry. 2005;27(1):36–43.SOBER S, SCHREIBER CA. Postpartum Contraception. Clin Obstet Gynecol. 2014;57(4):763–76.USAID, Johns Hopkins Bloomberg School of Public Health and Center For Communication Program, World Health Organization. Family Planning. A Global Handbook for Providers. 2018. 2018.Lester F, Kakaire O, Byamugisha J, Averbach S, Fortin J, Maurer R, et al. Intracesarean insertion of the Copper T380A versus 6 weeks postcesarean: A randomized clinical trial. Contraception. 2015;91(3):198–203.WHO. Implementation Guide For The Medical Eligibility Criteria For Contraceptive Use And Selected Practice Recommendations For Contraceptive Use Guidelines. 2018.Report MW. U . S . Medical Eligibility Criteria for Contraceptive Use , 2016. Vol. 65. 2016.WHO. The ABC’s of Family Planning. 2010.Cleland J, Bernstein S, Ezeh A, Faundes A, Glasier A, Innis J. Sexual and Reproductive Health 3 Family planning : the unfi nished agenda. 2006;368.Titilope Oduyebo, MD, MPH; Lauren B. Zapata, PhD; Maegan E. Boutot, MS; Naomi K. Tepper, MD M, Kathryn M. Curtis, PhD; Denise V. D’Angelo, MPH; Polly A. Marchbanks, PhD; Maura K. Whiteman P, Marchbanks PA, Whiteman MK. Factors associated with postpartum use of long-acting reversible contraception. The American Journal of Obstetrics & Gynecology. 2019;221(1):43.e1-43.e11.Oddens BJ. DETERMINANTS OF CONTRACEPTIVE USE AMONG WOMEN OF REPRODUCTIVE AGE IN GREAT BRITAIN AND GERMANY II : PSYCHOLOGICAL FACTORS. J biosoc Sci. 1997;437–70.Belfield T, Ffsrh H. Best Practice & Research Clinical Obstetrics and Gynaecology Principles of contraceptive care : choice , acceptability and access. Best Pract Res Clin Obstet Gynaecol. 2009;23(2):177–85.Wellings K, Zhihong Z, Krentel A, Barrett G, Glasier A. Attitudes towards long- acting reversible methods of contraception in general practice in the UK. 2007;76:208–14.Hersh AR, Muñoz LF, Rincón M, Alvarez C, Tolosa JE, Moreno DJ, et al. Video compared to conversational contraceptive counseling during labor and maternity hospitalization in Colombia: A randomized trial. Contraception. 2018 Sep;98(3):210–4.Hebert LE, Hill BJ, Quinn M, Holl JL, Whitaker AK, Gilliam ML. Mobile contraceptive application use in a clinical setting in addition to standard contraceptive counseling: A randomized controlled trial. Contraception. 2018;98(4):281–7.Lohr PA, Aiken ARA, Forsyth T, Trussell J. Telephone or integrated contraception counselling before abortion: Impact on method choice and receipt. BMJ Sex Reprod Health. 2018;44(2):114–21.Koo HP, Wilson EK, Minnis AM. A Computerized Family Planning Counseling Aid: A Pilot Study Evaluation of Smart Choices. Perspect Sex Reprod Health. 2017;49(1):45–53.Sapkota S, Rajbhandary R, Lohani S. The Impact of Balanced Counseling on Contraceptive Method Choice and Determinants of Long Acting and Reversible Contraceptive Continuation in Nepal. Matern Child Health J. 2017;21(9):1713–23.Sridhar A, Chen A, Forbes ER, Glik D. Mobile application for information on reversible contraception: A randomized controlled trial. Am J Obstet Gynecol. 2015;212(6):774.e1-774.e7.George T, DeCristofaro C, Dumas B, Murphy P. Shared Decision Aids: Increasing Patient Acceptance of Long-Acting Reversible Contraception. Healthcare. 2015;3(2):205–18.Farrokh-Eslamlou H, Aghlmand S, Eslami M, Homer CSE. Impact of the World Health Organization’s decision-making tool for family planning clients and providers on the quality of family planning services in Iran. Journal of Family Planning and Reproductive Health Care. 2014;40(2):89–95.Castaño PM, Bynum JY, Andrés R, Lara M, Westhoff C. Effect of daily text messages on oral contraceptive continuation: A randomized controlled trial. Obstetrics and Gynecology. 2012;119(1):14–20.Coleman-Minahan K, Potter JE. Quality of postpartum contraceptive counseling and changes in contraceptive method preferences. Contraception. 2019;100(6):492–7.Taub RL, Jensen JT. Advances in contraception: new options for postpartum women. Expert Opin Pharmacother. 2017;18(7):677–88.Delvoye P, Demaegd M, Uwayitu-Nyampeta, Robyn C. Serum prolactin, gonadotropins, and estradiol in menstruating and amenorrheic mothers during two years’ lactation. Am J Obstet Gynecol. 1978;130(6):635–9.Van der Wijden C, Brown J, Kleijnen J. Lactational amenorrhea for family planning. Cochrane Database of Systematic Reviews. 2003;(4).Meng K, Hu X, Peng X, Zhang Z. Incidence of venous thromboembolism during pregnancy and the puerperium: A systematic review and meta-analysis. Journal of Maternal-Fetal and Neonatal Medicine. 2015;28(3):245–53.Poulter NR, Meirik O. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives: Results of an international multicenter, case-control study. Contraception. 1998;57(5 SUPPL.):315–24.Simmons KB, Edelman AB, Li H, Yanit KE, Jensen JT. Personalized contraceptive assistance and uptake of long-acting, reversible contraceptives by postpartum women: A randomized, controlled trial. Contraception. 2013;88(1):45–51.Fda. NEXPLANON (etonogestrel implant) IMPLANON (etonogestrel implant).FECOLSOG. FECOLSOG. 2017. Anticoncepción Post Evento de Morbilidad Materna Extrema Anticoncepción Post Evento de Morbilidad. Available from: https://fecolsog.org/articulos-noticias/anticoncepcion-post-evento-de- morbilidad-materna-extrema/Fda. JADELLE (levonorgestrel implants) for subdermal use.UNDP/UNFPA/WHO/World Bank Special Programme of Research D and RT in HR (HRP). External evaluation 2003–2007; Long-term safety and effectiveness of copper-releasing intrauterine devices: a case-study. 2008.Reversible L acting, Devices I. Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices. 2018;131(735):130–9.fda, cder. ParaGard ® T380A INTRAUTERINE COPPER CONTRACEPTIVE PRESCRIBING INFORMATION ParaGard ® T 380A Intrauterine Copper Contraceptive.De D, Cruz A, Arteaga M, Castillo L, Tovalin H. Blood copper levels in Mexican users of the T380A IUD. Contraception. 2005;72(2):122–5.Stanford JB, Mikolajczyk RT. Mechanisms of action of intrauterine devices: Update and estimation of postfertilization effects. Vol. 187, American Journal of Obstetrics and Gynecology. Mosby Inc.; 2002. p. 1699–708.Heinemann K, Reed S, Moehner S, Do Minh T. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: The European Active Surveillance Study for Intrauterine Devices. Contraception. 2015 Apr 1;91(4):280–3.Cwiak C, Cordes S. Postpartum intrauterine device placement: a patient- friendly option. Contracept Reprod Med. 2018;3(1):3–7.Secura, Gina M., PhD, MPH; Allsworth, Jenifer E., PhD; Madden, Tessa, MD, MPH; Mullersman, Jennifer L., BSN; Peipert, Jeffrey F., MD P. The Contraceptive CHOICE Project: Reducing Barriers to LongActing Reversible Contraception. Am J Obstet Gynecol. 2010;203(2):115.Aoun J, Dines VA, Gomez-lobo V, Stovall DW, Nelson CB. Effects of Age , Parity , and Device Type on Complications and Discontinuation of Intrauterine Devices. Obstetrics & Gynecology. 2014;123(3):585–92.Berenson AB, Tan A, Hirth JM WGS. Complications and Continuation of Intrauterine Device Use Among Commercially Insured Teenagers. Obstetrics & Gynecology. 2014;121(5):951–8.Berenson AB, Tan A, Hirth JM WGS. Complications and Continuation of Intrauterine Device Use Among Commercially Insured Teenagers. Obstetrics & Gynecology. 2014;121(5):951–8.Luchowski AT, Anderson BL, Power ML, Raglan GB, Espey E, Schulkin J. Obstetrician – Gynecologists and contraception : practice and opinions about the use of IUDs in nulliparous women , adolescents and other. Contraception. 2014;89(6):572–7.Teal SB, Romer SE, Lisa M, Peters MG, Kaplan DW. Insertion Characteristics of Intrauterine Devices in Adolescents and Young Women: Success, Ancillary Measures, and Complications. Am J Obstet Gynecol. 2015;213(4):515.e1-5.Cleland K, Raymond EG, Westley E, Trussell J. Emergency contraception review: Evidence-based recommendations for clinicians. Vol. 57, Clinical Obstetrics and Gynecology. Lippincott Williams and Wilkins; 2014. p. 741–50.Bahamondes L, Bahamondes MV, Shulman LP. Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods. Hum Reprod Update. 2015;0(0):1–12.Cortessis VK, Barrett M, BrownWade N, Enebish T, Perrigo JL, Tobin J, et al. Intrauterine device use and cervical cancer risk: A systematic review and meta-analysis. In: Obstetrics and Gynecology. Lippincott Williams and Wilkins; 2017. p. 1226–36.Gómez Sanchéz PI. Anticoncepcion: Pasado, presente y futuro. Bogotá: Univesidad Nacional de Colombia; 2010.Goldthwaite LM, Cahill EP, Voedisch AJ, Blumenthal PD. Postpartum intrauterine devices: clinical and programmatic review. Am J Obstet Gynecol. 2018;219(3):235–41.Chen BA, Reeves MF, Hayes JL, Hohmann HL, Perriera LK, Creinin MD. Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: A randomized controlled trial. Obstetrics and Gynecology. 2010;116(5):1079–87.Whitaker AK, Endres LK, Mistretta SQ, Gilliam ML. Postplacental insertion of the levonorgestrel intrauterine device after cesarean delivery vs. delayed insertion: A randomized controlled trial. Contraception. 2014;89(6):534–9.Sonalkar S, Kapp N. Intrauterine device insertion in the postpartum period: A systematic review. European Journal of Contraception and Reproductive Health Care. 2015;20(1):4–18.Farley TMM, Rowe PJ, Meirik O, Rosenberg MJ, Chen JH. Intrauterine devices and pelvic inflammatory disease: an international perspective. The Lancet. 1992 Mar;339(8796):785–8.Toivonen J. Intrauterine Contraceptive Device and Pelvic Inflammatory Disease. Ann Med. 1993 Jan 8;25(2):171–3.Borda MR, Winfrey W, McKaig C. Return to sexual activity and modern family planning use in the extended postpartum period: an analysis of findings from seventeen countries. Afr J Reprod Health. 2010;14(4 Spec no.):72–9.Branum AM, Jones J. Trends in long-acting reversible contraception use among U.S. women aged 15-44. NCHS Data Brief. 2015;(188):1–8.Zerden ML, Tang JH, Stuart GS, Norton DR, Verbiest SB, Brody S. Barriers to Receiving Long-acting Reversible Contraception in the Postpartum Period. Women’s Health Issues. 2015;25(6):616–21.Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, et al. Effectiveness of long-acting reversible contraception. Obstet Gynecol Surv. 2012;67(9):552–3.Cleland J, Ali M, Benova L, Daniele M. The promotion of intrauterine contraception in low- and middle-income countries: a narrative review. Contraception. 2017;95(6):519–28.Pradhan E, Canning D, Shah IH, Puri M, Pearson E, Thapa K, et al. Integrating postpartum contraceptive counseling and IUD insertion services into maternity care in Nepal: Results from stepped-wedge randomized controlled trial. Reprod Health. 2019;16(1):1–15.Zapata, Lauren B., PhD; Murtaza, Sarah, MPH; Whiteman, Maura K., PhD; Jamieson, Denise J., MD; Robbins, Cheryl L., PhD; Marchbanks, Polly A., PhD; D’Angelo, Denise V, MPH; Curtis, Kathryn M. PhD. Contraceptive counseling and postpartum contraceptive use. Am J Obstet Gynecol. 2015;212(2):171.Hernandez LE, Sappenfield WM, Goodman D, Pooler J. Is effective contraceptive use conceived prenatally in Florida? the association between prenatal contraceptive counseling and postpartum contraceptive use. Matern Child Health J. 2012;16(2):423–9.Harper KD, Loper AC, Louison LM, Morse JE. Stage-based implementation of immediate postpartum long-acting reversible contraception using a reproductive justice framework. Am J Obstet Gynecol. 2020 Apr 1;222(4):S893–905.George IE Eluwa, Ronke Atamewalen, Kingsley Odogwu BA. Success Providing Postpartum Intrauterine Devices in. Glob Health Sci Pract. 2016;4(2):1–6.Pleah T, Hyjazi Y, Austin S, Diallo A, Dao B, Waxman R, et al. Increasing use of postpartum family planning and the postpartum IUD: Early experiences in west and central Africa. In: Global Health Science and Practice. Johns Hopkins University Press; 2016. p. S140–52.Pfitzer A, Mackenzie D, Blanchard H, Hyjazi Y, Kumar S, Lisanework Kassa S, et al. A facility birth can be the time to start family planning: Postpartum intrauterine device experiences from six countries. International Journal of Gynecology & Obstetrics. 2015 Jun 1;130(S2):S54–61.Huang Y, Merkatz R, Zhu H, Roberts K, Sitruk-Ware R, Cheng L. The free perinatal/postpartum contraceptive services project for migrant women in Shanghai: Effects on the incidence of unintended pregnancy. Contraception. 2014 Jun 1;89(6):521–7.Ortiz-González KM, Benabe E, Rivera-Rosa E, Negrón I, Romaguera J. Knowledge and choices of postpartum contraception among pregnant teens. P R Health Sci J. 2014;33(3):117–21.Lopez LM, Hiller JE, Grimes DA, Chen M. Education for contraceptive use by women after childbirth. Cochrane Database of Systematic Reviews. 2012;(8).Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception. Obstetrics and gynecology. 2016 Aug;128(2):e32- 7.Huang P, Yao J, Liu X, Luo B. Individualized intervention to improve rates of exclusive breastfeeding. Medicine. 2019 Nov;98(47):e17822.Torres-Cantero AM, Álvarez León EE, Morán-Sánchez I, San Lázaro Campillo I, Bernal Morell E, Hernández Pereña M, et al. El impacto de la pandemia de COVID-19 sobre la salud. Informe SESPAS 2022. Gac Sanit. 2022;36:S4–12.Perez T, Perez RL, Roman J. Conducting Clinical Research in the Era of Covid-19. Am J Med Sci. 2020 Sep;360(3):213–5.Almufleh A, Joseph J. The time is now: role of pragmatic clinical trials in guiding response to global pandemics. Trials. 2021 Dec 24;22(1):229.Bierer BE, White SA, Barnes JM, Gelinas L. Ethical Challenges in Clinical Research During the COVID-19 Pandemic. J Bioeth Inq. 2020 Dec 9;17(4):717–22.Meyer MN, Gelinas L, Bierer BE, Hull SC, Joffe S, Magnus D, et al. An ethics framework for consolidating and prioritizing COVID-19 clinical trials. Clinical Trials. 2021 Apr 2;18(2):226–33.Madariaga A, Kasherman L, Karakasis K, Degendorfer P, Heesters AM, Xu W, et al. Optimizing clinical research procedures in public health emergencies. Med Res Rev. 2021 Mar 11;41(2):725–38.https://apolo.unab.edu.co/en/persons/margarita-navarro-rubianoORIGINAL2023_Tesis_Eduardo_Zuñiga.pdf2023_Tesis_Eduardo_Zuñiga.pdfTesisapplication/pdf928481https://repository.unab.edu.co/bitstream/20.500.12749/21121/1/2023_Tesis_Eduardo_Zu%c3%b1iga.pdf0b4e4a6bbf9e200638dbe2bc4e6f3787MD51open access2023_Licencia_Eduardo_Zuñiga.pdf2023_Licencia_Eduardo_Zuñiga.pdfLicenciaapplication/pdf582755https://repository.unab.edu.co/bitstream/20.500.12749/21121/5/2023_Licencia_Eduardo_Zu%c3%b1iga.pdf8d29ccd276c0e2f8b51bdcf3cdc6dbd5MD55metadata only accessLICENSElicense.txtlicense.txttext/plain; charset=utf-8829https://repository.unab.edu.co/bitstream/20.500.12749/21121/4/license.txt3755c0cfdb77e29f2b9125d7a45dd316MD54open accessTHUMBNAIL2023_Tesis_Eduardo_Zuñiga.pdf.jpg2023_Tesis_Eduardo_Zuñiga.pdf.jpgIM Thumbnailimage/jpeg5384https://repository.unab.edu.co/bitstream/20.500.12749/21121/6/2023_Tesis_Eduardo_Zu%c3%b1iga.pdf.jpg61ddc5db993ca8ff82724a83baa2ab1cMD56open access2023_Licencia_Eduardo_Zuñiga.pdf.jpg2023_Licencia_Eduardo_Zuñiga.pdf.jpgIM Thumbnailimage/jpeg13160https://repository.unab.edu.co/bitstream/20.500.12749/21121/7/2023_Licencia_Eduardo_Zu%c3%b1iga.pdf.jpg07a9151e0a8c49f685ebc5cdda1a6a95MD57metadata only access20.500.12749/21121oai:repository.unab.edu.co:20.500.12749/211212023-08-09 22:01:08.616open accessRepositorio Institucional | Universidad Autónoma de Bucaramanga - UNABrepositorio@unab.edu.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

Publicaciones similares